Purpose: To track use and health risks associated with controlled substances.
Key Information: Number of prescriptions for controlled substances by schedule, type of drug, and prescriber.
Collection Period: 2009 to present.
Rhode Island Numbers
In October 2014 - Hydrocodone containing products moved from Schedule III to Schedule II.
While the number of prescriptions for stimulants continues to rise, there is a downward trend in the number of prescriptions for pain at the beginning of 2014.
The vast majority of prescribers are not using the Prescription Monitoring Program when they prescribe Schedule 2 drugs to check and see if the patient has other prescriptions.
While there is much opportunity for improvement, utilization of PMP reached its highest level in July 2015.
The recommended best practice is for providers to check the Prescription Monitoring Program before every Schedule 2 prescription is written.
Rhode Island ranks 4th in the US for benzodiazepine use per capita.
The number of individuals who were dispensed Schedule 2,3 drugs from more than 4 prescribers and more than 4 phamacies in a year doubled from 2004 to 2013. While the numbers have dropped a bit from 2011 there are still close to 1000 people a year who exhibit this abusive behavior.
We believe that increased utilization of the Prescription Monitoring Program by doctors and pharmacists will sharpen the downward trend.
Buprenorphine is used as part of Medication-Assisted Treatment (MAT) for patients who suffer from the chronic disease of addiction or opioid dependence.
The doses of the buprenorphine dispensed, used as part of Medication-Assisted Treatment (MAT) for patients who suffer from the chronic disease of addiction or those with opioid dependence has increased since January 2013.